Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation.

What Was Tested

Researchers studied Transcranial Magnetic Stimulation in this clinical trial publication.

Repetitive transcranial magnetic stimulation (rTMS) has been used to treat symptoms from many disorders; biochemical changes occurred with this treatment.

To obtain more information about these changes after rTMS, the researchers measured changes in several CA enzymes, proteins, and trace metals in their blood plasma, erythrocytes, and saliva.

Who Took Part

PubMed indexes the participants as teenagers, young adults, adults, middle-aged adults, older adults and people over 80, both men and women.

How the Study Was Run

Before and after rTMS, the researchers measured erythrocyte CA I, II and salivary CA VI, zinc and copper in parotid saliva, blood plasma, and erythrocytes, and appearance of novel salivary proteins by using mass spectrometry.

What Was Measured

To obtain more information about these changes after rTMS, the researchers measured changes in several CA enzymes, proteins, and trace metals in their blood plasma, erythrocytes, and saliva.

PubMed files the paper under topics including Carbonic Anhydrase I, Carbonic Anhydrase II, Carbonic Anhydrases, Copper, Erythrocytes, Saliva and Taste Disorders.

What This Means in Plain Language

This is a clinical trial of Transcranial Magnetic Stimulation.

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2010 (The American journal of the medical sciences), a journal based in United States.

More context: all human trials.